International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -52.8% | 21.3% | -67.7% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 28.2% | 100% | 104.4% | 83.6% |
| EBITDA | -£0 | £0 | £0 | -£0 |
| % Margin | -157.7% | 0% | 100.5% | -1.9% |
| Net Income | -£0 | £0 | £0 | £0 |
| % Margin | -136.9% | 55.4% | 100.7% | 87.4% |
| EPS Diluted | -0.23 | 0.19 | 0.29 | 0.73 |
| % Growth | -221.1% | -34.5% | -60.3% | – |
| Operating Cash Flow | £0 | -£0 | -£0 | £0 |
| Capital Expenditures | -£0 | £0 | £0 | £0 |
| Free Cash Flow | £0 | -£0 | -£0 | £0 |